Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
$0.00
$0.00
$0.00
N/AN/AN/A11,500 shs
Franchise Group, Inc. stock logo
FRG
Franchise Group
$29.88
$29.83
$22.45
$37.89
$1.05B1.69777,279 shsN/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
0.00%0.00%0.00%0.00%0.00%
Franchise Group, Inc. stock logo
FRG
Franchise Group
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
Franchise Group, Inc. stock logo
FRG
Franchise Group
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
0.00
N/AN/AN/A
Franchise Group, Inc. stock logo
FRG
Franchise Group
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
N/AN/AN/AN/AN/AN/A
Franchise Group, Inc. stock logo
FRG
Franchise Group
$4.31B0.24$11.19 per share2.67$6.40 per share4.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Franchise Group, Inc. stock logo
FRG
Franchise Group
-$68.57M-$7.83N/A9.641.21-6.52%11.30%1.15%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
N/AN/AN/AN/AN/A
Franchise Group, Inc. stock logo
FRG
Franchise Group
$2.508.37%+115.44%N/A N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
N/AN/AN/A
Franchise Group, Inc. stock logo
FRG
Franchise Group
6.77
1.37
0.60

Institutional Ownership

CompanyInstitutional Ownership
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
N/A
Franchise Group, Inc. stock logo
FRG
Franchise Group
88.75%

Insider Ownership

CompanyInsider Ownership
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
N/A
Franchise Group, Inc. stock logo
FRG
Franchise Group
36.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biomark Diagnostics Inc. stock logo
BUX
Biomark Diagnostics
N/AN/AN/ANot Optionable
Franchise Group, Inc. stock logo
FRG
Franchise Group
14,23735.19 million22.52 millionOptionable

Recent News About These Companies

FRG Lawyers Called Too Conflicted for Bankruptcy by US Trustee
American Freight to close all stores nationwide

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biomark Diagnostics stock logo

Biomark Diagnostics CNSX:BUX

BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.

Franchise Group stock logo

Franchise Group NASDAQ:FRG

Franchise Group, Inc. owns and operates franchised and franchisable businesses. It operates through six segments: Vitamin Shoppe, Pet Supplies Plus, Badcock, American Freight, Buddy's, and Sylvan. The Vitamin Shoppe segment operates as an omnichannel specialty retailer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Pet Supplies Plus segment operates as an omnichannel retail chain and franchisor of pet supplies and services that includes premium brands, proprietary private labels, and specialty products, as well as offers grooming, pet wash, and other services. The Badcock segment operates as a specialty retailer of furniture, appliances, bedding, electronics, home office equipment, accessories, and seasonal items in a showroom format; and offers multiple and flexible payment solutions and credit options through its consumer financing services. The American Freight segment operates a retail chain the provides in-store and online access to furniture, mattresses, new and out-of-box home appliances, and home accessories; and serves as a liquidation channel for appliance vendors. The Buddy's segment operates as a specialty retailer of consumer electronic, residential furniture, appliances, and household accessories through rent-to-own agreements. The Sylvan segment establishes and grows as a franchisor of supplemental education for Pre-K-12 students and families in the United States and Canada. The company was formerly known as Liberty Tax, Inc., and changed its name to Franchise Group, Inc. in September 2019. Franchise Group, Inc. was incorporated in 2010 and is headquartered in Delaware, Ohio.